Most of the guidance in the planning your application section of the PHST Recruitment website. This page details where there are differences.

Assessment methods

The basic structure of IMY3 assessment is the same as PHST, with shortlisting assessed via a verified self-assessment and an interview used to determine appointability. 

The self-assessment scoring matrix is exactly the same one used as PHST recruitment, so the application scoring section of that website contains details. Something to note is that the PHST Recruitment website will not be updated for 2025 recruitment until late October 2024. In the interim, you can refer to the Document Library for details of planned changes to 2025 application scoring.

Differences to PHST include: 

  • No commitment to specialty assessment as part of shortlisting - as IMY3 is a core level programme, this is not being assessed as the experience and capability requirements to be eligible are sufficient demonstration of commitment to internal medicine. 
  • Additional internal medicine capability assessment as part of shortlisting - as noted in the core capability section, there will be a review of your experience and capability in geriatric medicine and critical care.

Evidence documents

This is the same as PHST, with the exception that additional evidence for geriatric medicine and critical care capability will be required. 

ACF clinical benchmarking

This does not apply to IMY3 and the IMY3 process cannot be used as a method to be clinically benchmarked for a Group 1 physician specialty academic clinical fellowship.

Round 2 and future recruitment

There is not expected to be a second round of IMY3 recruitment in 2025. 

IMY3 is currently a pilot recruitment process and a decision on recruitment beyond 2025 will be made in the summer of 2025. This will include whether to continue with recruitment at all and, if so, whether it will be extended to other regions of the United Kingdom.